MARKET INSIGHTS

The Asia Pacific Cobalt‑60 market was valued at USD 132.7 million in 2024 and is expected to rise from USD 141.8 million in 2025 to USD 199.6 million by 2032, reflecting a compound annual growth rate of 4.9 % during the forecast period.

Cobalt‑60 is a radioactive isotope prized for its gamma‑ray output, which is essential for cancer radiotherapy, industrial radiography, and sterilisation of medical devices and food products. Its capacity to penetrate materials without residual radioactivity makes it a unique asset across healthcare and industrial applications.

Demand is propelled by expanding oncology infrastructure in emerging economies, where Cobalt‑60‑based radiotherapy offers a cost‑effective solution for developing nations. Simultaneously, tightening regulatory standards for medical device sterilisation and food safety sustain the need for the isotope. The market faces headwinds from alternative sterilisation technologies such as electron beam, which captured 12 % of the medical segment share since 2022. Leading players – China National Nuclear Corporation and Board of Radiation and Isotope Technology – are bolstering production capacity, with China supplying 38 % of regional output as of 2024.

Asia Pacific Cobalt‑60 Market – View in Detailed Research Report

Top 10 Companies in the Asia Pacific Cobalt‑60 Market

Below are the market leaders, ranked by their influence on supply, technology, and geographic reach.

1️⃣ China National Nuclear Corporation (CNNC)

Headquarters: Beijing, China
Key Offering: Cobalt‑60 isotope production, sealed source manufacturing, and irradiation services

CNNC commands the largest share of the regional supply chain, operating state‑backed reactors and dedicated isotope production lines. Its recent investment of USD 120 million in new production facilities is projected to boost output by 25 % by 2026, positioning CNNC as the backbone of both domestic and export demand.

Sustainability & Growth Initiatives:

• Expansion of domestic production to reduce import dependence
• Strategic partnerships with regional governments to support public‑health irradiation programmes
• Investment in digital monitoring systems to enhance safety compliance

2️⃣ Nordion Inc.

Headquarters: Ottawa, Canada
Key Offering: High‑specific‑activity Cobalt‑60 sources and gamma‑irradiation equipment

Nordion’s portfolio spans high‑activity sources for medical radiotherapy and industrial sterilisation, making it a preferred supplier for hospitals and food‑processing facilities across the region.

Sustainability & Growth Initiatives:

• Development of low‑emission production processes
• Collaboration with research institutions to advance isotope handling protocols
• Expansion of service contracts in Southeast Asia

3️⃣ Board of Radiation and Isotope Technology (BRIT)

Headquarters: New Delhi, India
Key Offering: Cobalt‑60 production, irradiation services, and regulatory compliance support

BRIT’s integrated model covers isotope generation, source fabrication, and on‑site irradiation, enabling rapid deployment of sterilisation facilities in India’s growing medical device sector.

Sustainability & Growth Initiatives:

• Investment in new irradiation plants to meet rising domestic demand
• Training programmes for radiation safety officers
• Partnerships with local manufacturers to promote single‑use device sterilisation

4️⃣ Korea Hydro & Nuclear Power Co., Ltd. (KHNP)

Headquarters: Seoul, South Korea
Key Offering: Cobalt‑60 production and high‑precision radiotherapy equipment

KHNP leverages its nuclear expertise to supply high‑specific‑activity sources for advanced cancer treatment units, supporting South Korea’s reputation for medical technology excellence.

Sustainability & Growth Initiatives:

• Expansion of domestic irradiation capacity to serve the regional market
• Collaboration with academic institutions on isotope research
• Implementation of advanced safety monitoring systems

5️⃣ Australian Nuclear Science and Technology Organisation (ANSTO)

Headquarters: Canberra, Australia
Key Offering: Research‑grade Cobalt‑60 sources and irradiation technology

ANSTO’s focus on research and development positions it as a technology leader, supplying high‑quality sources to Australian and regional medical facilities.

Sustainability & Growth Initiatives:

• Investment in next‑generation irradiation platforms
• Collaborative projects with industry to reduce sterilisation times
• Public education campaigns on radiation safety

6️⃣ Shanghai Institute of Applied Physics (Chinese Academy of Sciences)

Headquarters: Shanghai, China
Key Offering: Advanced isotope research and development, prototype irradiation systems

The institute’s research output fuels innovation in isotope production, feeding CNNC’s supply chain and advancing new applications.

Sustainability & Growth Initiatives:

• Development of high‑yield production methods
• Collaboration with industry partners for commercialisation
• Focus on reducing production energy consumption

7️⃣ Chiyoda Technol Corporation

Headquarters: Tokyo, Japan
Key Offering: Engineering and supply of gamma‑irradiation systems

Chiyoda provides turnkey irradiation solutions, enabling hospitals and food processors to install compliant facilities.

Sustainability & Growth Initiatives:

• Development of compact, energy‑efficient irradiation units
• Partnerships with local manufacturers to support sterilisation infrastructure
• Training programmes for operators

8️⃣ Fuji Electric Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Monitoring equipment for irradiation processes

Fuji Electric’s sensors and control systems ensure precise dose delivery, enhancing safety and compliance across irradiation facilities.

Sustainability & Growth Initiatives:

• Integration of IoT for real‑time monitoring
• Collaboration with regulatory bodies to streamline approvals
• Investment in energy‑efficient electronics

9️⃣ China Isotope & Radiation Corporation

Headquarters: Beijing, China
Key Offering: Cobalt‑60 source manufacturing and service provision

As a subsidiary of CNNC, the corporation expands production capacity and offers maintenance services to irradiation facilities.

Sustainability & Growth Initiatives:

• Expansion of production lines to meet growing demand
• Development of low‑emission source fabrication processes
• Partnerships with regional distributors

🔟 Japan Steel Works, Ltd.

Headquarters: Tokyo, Japan
Key Offering: Radiation‑shielded equipment and engineering services

Japan Steel Works supplies custom shielding solutions and engineering support for high‑dose irradiation facilities, ensuring compliance with stringent safety standards.

Sustainability & Growth Initiatives:

• Research into advanced shielding materials
• Collaboration with healthcare providers to optimise facility design
• Implementation of lean manufacturing practices

Download FREE Sample Report: Asia Pacific Cobalt‑60 Market – View in Detailed Research Report

Get Full Report Here: Asia Pacific Cobalt‑60 Market – View in Detailed Research Report

Outlook

From 2025 to 2032, the Asia Pacific Cobalt‑60 market will expand from USD 141.8 million to USD 199.6 million, driven by the region’s push for advanced cancer care and stricter sterilisation regulations. China, Japan, and India will remain the leading contributors, accounting for roughly 35 %, 25 %, and 20 % of the market, respectively. The expansion will be supported by a series of capacity upgrades, including CNNC’s new production lines and joint ventures between Australian and Indian nuclear agencies.

Future Trends

Key developments to watch include:

• Regulatory tightening on radiation safety, prompting investment in monitoring and compliance technology.
• Public‑health campaigns that could shift perception of irradiation, influencing adoption rates in food and medical sectors.
• Emerging alternative sterilisation methods, such as electron beam, that may erode Cobalt‑60’s market share in the next decade.
• Strategic alliances that streamline technology transfer, reducing supply chain bottlenecks and opening new markets in Southeast Asia.

These dynamics suggest a market that will remain competitive, with a clear focus on safety, capacity expansion, and technology innovation.